1. Home
  2. ANGO
  3. ANGO News

Latest AngioDynamics Inc. (ANGO) News on February 23, 2025

AngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?
ANGO

Zacks

16 days ago

AngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?

ANGO Stock Looks Promising on New Ischemia Study for Auryon System
ANGO

Zacks

23 days ago

ANGO Stock Looks Promising on New Ischemia Study for Auryon System

ANGO

Business Wire

24 days ago

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
ANGO

Simply Wall St.

a month ago

With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns

ANGO

Business Wire

a month ago

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
ANGO

Zacks

a month ago

AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines

AngioDynamics Reports Growth and Advances NanoKnife System
ANGO

TipRanks

a month ago

AngioDynamics Reports Growth and Advances NanoKnife System

AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
ANGO

GuruFocus.com

a month ago

AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ANGO

Thomson Reuters StreetEvents

a month ago

Q2 2025 AngioDynamics Inc Earnings Call

ANGO

MT Newswires

a month ago

AngioDynamics Shares Jump Following Fiscal Q2 Results

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
ANGO

Zacks

a month ago

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates

ANGO

Associated Press Finance

a month ago

AngioDynamics: Fiscal Q2 Earnings Snapshot

ANGO

Business Wire

a month ago

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
ANGO

GuruFocus.com

2 months ago

What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings

ANGO

Business Wire

2 months ago

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

ANGO

Business Wire

2 months ago

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

ANGO

Business Wire

2 months ago

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
ANGO

Zacks

2 months ago

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?
ANGO

Zacks

2 months ago

Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?

NanoKnife gains FDA clearance for prostate tissue ablation
ANGO

Medical Device Network

2 months ago

NanoKnife gains FDA clearance for prostate tissue ablation

ANGO

MT Newswires

2 months ago

AngioDynamics' NanoKnife System Receives FDA Clearance for Prostate Tissue Ablation

ANGO

Business Wire

2 months ago

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

NARI Stock Likely to Gain Following Reimbursement Approval in Japan
ANGO

Zacks

3 months ago

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System
ANGO

Zacks

3 months ago

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System

NVRO Stock Declines Despite Positive Study Data of Nevro1 System
ANGO

Zacks

3 months ago

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
ANGO

Zacks

3 months ago

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
ANGO

Zacks

4 months ago

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade
ANGO

Zacks

4 months ago

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade

GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
ANGO

Zacks

4 months ago

GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years
ANGO

Simply Wall St.

4 months ago

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years

AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?
ANGO

Zacks

4 months ago

AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?

AngioDynamics launches long-term study of NanoKnife for prostate cancer
ANGO

Clinical Trials Arena

4 months ago

AngioDynamics launches long-term study of NanoKnife for prostate cancer

ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE
ANGO

Zacks

4 months ago

ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE

ANGO

Business Wire

4 months ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments
ANGO

Medical Device Network

4 months ago

AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments

ANGO

Business Wire

4 months ago

AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

ANGO

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 10/11/2024

ANGO

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 10/09/2024

AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ANGO

Zacks

4 months ago

AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
ANGO

Zacks

5 months ago

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise

AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025
ANGO

TipRanks

5 months ago

AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025

ANGO

Thomson Reuters StreetEvents

5 months ago

Q1 2025 AngioDynamics Inc Earnings Call

AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...
ANGO

GuruFocus.com

5 months ago

AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...

Why AngioDynamics Stock Is Crashing Today
ANGO

Motley Fool

5 months ago

Why AngioDynamics Stock Is Crashing Today

Here's Why You Should Add AngioDynamics Stock to Your Portfolio
ANGO

Zacks

5 months ago

Here's Why You Should Add AngioDynamics Stock to Your Portfolio

AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates
ANGO

Zacks

5 months ago

AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates

ANGO

Associated Press Finance

5 months ago

AngioDynamics: Fiscal Q1 Earnings Snapshot

ANGO

Business Wire

5 months ago

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect
ANGO

GuruFocus.com

5 months ago

AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect

New Strong Buy Stocks for September 30th
ANGO

Zacks

5 months ago

New Strong Buy Stocks for September 30th

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe
ANGO

Zacks

5 months ago

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe

AngioDynamics initiates thrombectomy system trial across Europe
ANGO

Medical Device Network

5 months ago

AngioDynamics initiates thrombectomy system trial across Europe

ANGO

MT Newswires

5 months ago

AngioDynamics Starts Trial of AlphaVac System in Pulmonary Embolism Treatment

ANGO

Business Wire

5 months ago

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

ANGO

Business Wire

5 months ago

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

This AngioDynamics Insider Increased Their Holding In The Last Year
ANGO

Simply Wall St.

5 months ago

This AngioDynamics Insider Increased Their Holding In The Last Year

New Strong Buy Stocks for September 9th
ANGO

Zacks

5 months ago

New Strong Buy Stocks for September 9th

AngioDynamics Stock Falls Despite CE Mark for Auryon System
ANGO

Zacks

6 months ago

AngioDynamics Stock Falls Despite CE Mark for Auryon System

AngioDynamics wins EU CE mark for Auryon system to treat PAD
ANGO

Medical Device Network

6 months ago

AngioDynamics wins EU CE mark for Auryon system to treat PAD

ANGO

Business Wire

6 months ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching
ANGO

TipRanks

6 months ago

TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching

AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why
ANGO

Zacks

6 months ago

AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why

With 83% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
ANGO

Simply Wall St.

6 months ago

With 83% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns

AngioDynamics (ANGO) Down 3.1% Since Last Earnings Report: Can It Rebound?
ANGO

Zacks

6 months ago

AngioDynamics (ANGO) Down 3.1% Since Last Earnings Report: Can It Rebound?

Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
ANGO

Zacks

6 months ago

Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US

Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect?
ANGO

Zacks

6 months ago

Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect?

Should You Buy AngioDynamics (ANGO) After Golden Cross?
ANGO

Zacks

7 months ago

Should You Buy AngioDynamics (ANGO) After Golden Cross?

AngioDynamics to Participate in Upcoming Investor Conferences
ANGO

Business Wire

7 months ago

AngioDynamics to Participate in Upcoming Investor Conferences

Wall Street Analysts Predict a 74.25% Upside in AngioDynamics (ANGO): Here's What You Should Know
ANGO

Zacks

7 months ago

Wall Street Analysts Predict a 74.25% Upside in AngioDynamics (ANGO): Here's What You Should Know

AngioDynamics Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line
ANGO

Simply Wall St.

7 months ago

AngioDynamics Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
ANGO

Simply Wall St.

7 months ago

When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?

AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down
ANGO

Zacks

7 months ago

AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down

ANGO

Thomson Reuters StreetEvents

7 months ago

Q4 2024 AngioDynamics Inc Earnings Call

ANGO

MT Newswires

7 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

ANGO

MT Newswires

7 months ago

AngioDynamics Shares Rise After Fiscal Q4 Results, Share Repurchase Program

AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
ANGO

Zacks

7 months ago

AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates

ANGO

Associated Press Finance

7 months ago

AngioDynamics: Fiscal Q4 Earnings Snapshot

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
ANGO

Business Wire

7 months ago

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
ANGO

Business Wire

7 months ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

First patient implanted with Philips’ Duo Venous stent system
ANGO

Medical Device Network

8 months ago

First patient implanted with Philips’ Duo Venous stent system

AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
ANGO

Zacks

9 months ago

AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 75% over the last three years
ANGO

Simply Wall St.

9 months ago

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 75% over the last three years

ANGO

MT Newswires

9 months ago

AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
ANGO

Business Wire

9 months ago

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
ANGO

Business Wire

10 months ago

AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks
ANGO

TipRanks

10 months ago

Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks

Insider Spends US$67k Buying More Shares In AngioDynamics
ANGO

Simply Wall St.

10 months ago

Insider Spends US$67k Buying More Shares In AngioDynamics

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
ANGO

Insider Monkey

10 months ago

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript

AngioDynamics Third Quarter 2024 Earnings: Misses Expectations
ANGO

Simply Wall St.

a year ago

AngioDynamics Third Quarter 2024 Earnings: Misses Expectations

AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates
ANGO

Zacks

a year ago

AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
ANGO

Zacks

a year ago

AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment

ANGO

Thomson Reuters StreetEvents

a year ago

Q3 2024 AngioDynamics Inc Earnings Call

Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
ANGO

Benzinga

a year ago

Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars

AngioDynamics Inc (ANGO) Posts Q3 Fiscal 2024 Results: A Mixed Performance Amidst Asset Divestiture
ANGO

GuruFocus.com

a year ago

AngioDynamics Inc (ANGO) Posts Q3 Fiscal 2024 Results: A Mixed Performance Amidst Asset Divestiture

ANGO

Associated Press Finance

a year ago

AngioDynamics: Fiscal Q3 Earnings Snapshot

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
ANGO

Business Wire

a year ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
ANGO

Business Wire

a year ago

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

AngioDynamics (ANGO) Settles Patent Litigations With BD
ANGO

Zacks

a year ago

AngioDynamics (ANGO) Settles Patent Litigations With BD

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
ANGO

Business Wire

a year ago

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
ANGO

Zacks

a year ago

Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for

Share on Social Networks: